Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO)

Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
4. 43
-0.22
-4.7312%
$
248.5M Market Cap
- P/E Ratio
593% Div Yield
819,503 Volume
-2.23 Eps
$ 4.65
Previous Close
Add Transaction
Day Range
4.39 4.66
Year Range
4 7.65
Want to track ABEO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Abeona Therapeutics Inc. (ABEO) Statistics

Valuation metrics

Market Cap 248.5M
Enterprise value 245.2M
Trailing P/E (ttm) -4.35
Forward P/E 19.26
PEG ratio 0.02
Price/Sales (ttm) 11.03
Price/Book (mrq) 2.2
Enterprise Value/Revenue 9.61
Enterprise Value/EBITDA -3.44

Overview

Shares outstanding 56.87M
Float 36.34M
Shares short 16.49M
% Held by insiders 0.17%
% Held by institutions 0.71%
Average volume (10 days) 1.38M
Average volume (90 days) 1.37M

Price summary

52-Week low 4
52-Week high 7.65
Beta 1.34
50-Day moving average 5.23
200-Day moving average 5.62

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 5 Jul 2022

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -2.46%
Operating margin -3.28%

Operational effectiveness

Return on assets -0.35%
Return on equity -0.42%

Income Statement

Revenue (ttm) 14.54M
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) 0.61%
Gross profit (ttm) -18.01M
EBITDA 72.45M
Net income to common (ttm) 66.14M
Diluted EPS (ttm) -1.1
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 168.27M
Total cash per share (mrq) 2.57
Total debt (mrq) 23.17M
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 6.63%
Book value per share (mrq) 2.24

Cash Flow

Cash flow statement -77.73M
Levered free cash flow (LFCF) -56.59M